

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 8.87004822 |
| 2 | triglyceride catabolic process (GO:0019433) | 8.45724926 |
| 3 | acylglycerol catabolic process (GO:0046464) | 7.63490644 |
| 4 | neutral lipid catabolic process (GO:0046461) | 7.63490644 |
| 5 | fatty acid homeostasis (GO:0055089) | 7.55505642 |
| 6 | diacylglycerol metabolic process (GO:0046339) | 6.80947347 |
| 7 | glycerolipid catabolic process (GO:0046503) | 5.83665183 |
| 8 | biotin metabolic process (GO:0006768) | 5.63459885 |
| 9 | brown fat cell differentiation (GO:0050873) | 5.53226790 |
| 10 | plasma lipoprotein particle clearance (GO:0034381) | 5.38269161 |
| 11 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 5.35584018 |
| 12 | amino acid import (GO:0043090) | 5.30353643 |
| 13 | L-amino acid import (GO:0043092) | 5.17472576 |
| 14 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.09421956 |
| 15 | CDP-diacylglycerol metabolic process (GO:0046341) | 5.09210380 |
| 16 | lipid storage (GO:0019915) | 5.07654853 |
| 17 | C4-dicarboxylate transport (GO:0015740) | 5.00144434 |
| 18 | white fat cell differentiation (GO:0050872) | 4.96381325 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 4.89905094 |
| 20 | regulation of cholesterol storage (GO:0010885) | 4.77802526 |
| 21 | triglyceride metabolic process (GO:0006641) | 4.74766693 |
| 22 | negative regulation of astrocyte differentiation (GO:0048712) | 4.73042672 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 4.71981969 |
| 24 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 4.66785265 |
| 25 | glycerol metabolic process (GO:0006071) | 4.64905882 |
| 26 | * alanine transport (GO:0032328) | 4.52997109 |
| 27 | lipid particle organization (GO:0034389) | 4.51608032 |
| 28 | acylglycerol metabolic process (GO:0006639) | 4.41992196 |
| 29 | cellular response to cholesterol (GO:0071397) | 4.41620924 |
| 30 | sodium ion export (GO:0071436) | 4.40224818 |
| 31 | proline transport (GO:0015824) | 4.37022382 |
| 32 | neutral lipid metabolic process (GO:0006638) | 4.36723793 |
| 33 | positive regulation of lipid storage (GO:0010884) | 4.34128950 |
| 34 | cell communication by electrical coupling (GO:0010644) | 4.33437905 |
| 35 | gamma-aminobutyric acid transport (GO:0015812) | 4.30504278 |
| 36 | response to dietary excess (GO:0002021) | 4.22805936 |
| 37 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 4.09095204 |
| 38 | cGMP-mediated signaling (GO:0019934) | 4.07218680 |
| 39 | low-density lipoprotein particle remodeling (GO:0034374) | 4.05924259 |
| 40 | positive regulation of cholesterol efflux (GO:0010875) | 4.04429988 |
| 41 | alditol metabolic process (GO:0019400) | 4.04324870 |
| 42 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.97823642 |
| 43 | positive regulation of glomerulus development (GO:0090193) | 3.97396231 |
| 44 | acetyl-CoA metabolic process (GO:0006084) | 3.97133044 |
| 45 | carnitine shuttle (GO:0006853) | 3.93500780 |
| 46 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.92720930 |
| 47 | thioester metabolic process (GO:0035383) | 3.92608065 |
| 48 | acyl-CoA metabolic process (GO:0006637) | 3.92608065 |
| 49 | response to phenylpropanoid (GO:0080184) | 3.90915324 |
| 50 | cellular sodium ion homeostasis (GO:0006883) | 3.89938598 |
| 51 | NADH metabolic process (GO:0006734) | 3.86707172 |
| 52 | axon ensheathment in central nervous system (GO:0032291) | 3.86276705 |
| 53 | central nervous system myelination (GO:0022010) | 3.86276705 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.85286027 |
| 55 | retinol metabolic process (GO:0042572) | 3.77005807 |
| 56 | regulation of phospholipid biosynthetic process (GO:0071071) | 3.75075303 |
| 57 | neurotransmitter uptake (GO:0001504) | 3.74580502 |
| 58 | phospholipid homeostasis (GO:0055091) | 3.70301052 |
| 59 | cellular response to sterol (GO:0036315) | 3.67230688 |
| 60 | chondroitin sulfate catabolic process (GO:0030207) | 3.65335204 |
| 61 | atrial cardiac muscle cell action potential (GO:0086014) | 3.62332489 |
| 62 | potassium ion import (GO:0010107) | 3.62191115 |
| 63 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.58257791 |
| 64 | regulation of heat generation (GO:0031650) | 3.57788124 |
| 65 | polyol transport (GO:0015791) | 3.57655837 |
| 66 | ethanol oxidation (GO:0006069) | 3.57364036 |
| 67 | positive regulation of cholesterol transport (GO:0032376) | 3.57336784 |
| 68 | positive regulation of sterol transport (GO:0032373) | 3.57336784 |
| 69 | triglyceride homeostasis (GO:0070328) | 3.56890628 |
| 70 | acylglycerol homeostasis (GO:0055090) | 3.56890628 |
| 71 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.54030116 |
| 72 | primary alcohol metabolic process (GO:0034308) | 3.53947576 |
| 73 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.53558339 |
| 74 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.50700318 |
| 75 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.48495731 |
| 76 | protein heterotrimerization (GO:0070208) | 3.42143914 |
| 77 | phosphatidic acid biosynthetic process (GO:0006654) | 3.41435531 |
| 78 | phosphatidic acid metabolic process (GO:0046473) | 3.41435531 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.40026503 |
| 80 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.39295780 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.35237229 |
| 82 | positive regulation of fatty acid oxidation (GO:0046321) | 3.33718669 |
| 83 | response to auditory stimulus (GO:0010996) | 3.33338881 |
| 84 | regulation of lipid storage (GO:0010883) | 3.33024910 |
| 85 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.32909541 |
| 86 | negative regulation of macrophage differentiation (GO:0045650) | 3.30682459 |
| 87 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.30559148 |
| 88 | * L-serine transport (GO:0015825) | 3.29711919 |
| 89 | locomotory exploration behavior (GO:0035641) | 3.28207892 |
| 90 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.26989599 |
| 91 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.24877946 |
| 92 | dermatan sulfate biosynthetic process (GO:0030208) | 3.23816284 |
| 93 | oxaloacetate metabolic process (GO:0006107) | 3.22737756 |
| 94 | regulation of triglyceride catabolic process (GO:0010896) | 3.22705183 |
| 95 | glutamate receptor signaling pathway (GO:0007215) | 3.20755480 |
| 96 | regulation of beta-amyloid formation (GO:1902003) | 3.19695529 |
| 97 | adenine nucleotide transport (GO:0051503) | 3.19525957 |
| 98 | potassium ion homeostasis (GO:0055075) | 3.17183243 |
| 99 | negative regulation of protein autophosphorylation (GO:0031953) | 3.16306061 |
| 100 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.15018045 |
| 101 | glial cell proliferation (GO:0014009) | 3.14705606 |
| 102 | dermatan sulfate metabolic process (GO:0030205) | 3.13321732 |
| 103 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.12451872 |
| 104 | regulation of astrocyte differentiation (GO:0048710) | 3.11955511 |
| 105 | tricarboxylic acid metabolic process (GO:0072350) | 3.11083463 |
| 106 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.10167225 |
| 107 | regulation of triglyceride metabolic process (GO:0090207) | 3.09931892 |
| 108 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.09526939 |
| 109 | negative regulation of sodium ion transport (GO:0010766) | 3.06679751 |
| 110 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.01033359 |
| 111 | glycine transport (GO:0015816) | 3.00063083 |
| 112 | acidic amino acid transport (GO:0015800) | 2.98644835 |
| 113 | negative regulation of lipid catabolic process (GO:0050995) | 2.96745838 |
| 114 | auditory behavior (GO:0031223) | 2.95991371 |
| 115 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.95344827 |
| 116 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.92641307 |
| 117 | cellular response to lithium ion (GO:0071285) | 2.92489255 |
| 118 | transcytosis (GO:0045056) | 2.92342609 |
| 119 | negative regulation of gluconeogenesis (GO:0045721) | 2.89082764 |
| 120 | blood vessel maturation (GO:0001955) | 2.88244796 |
| 121 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.88069399 |
| 122 | cellular response to epinephrine stimulus (GO:0071872) | 2.86476472 |
| 123 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.86229326 |
| 124 | coenzyme A biosynthetic process (GO:0015937) | 2.85009260 |
| 125 | ethanol metabolic process (GO:0006067) | 2.84732877 |
| 126 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.84455138 |
| 127 | ovulation cycle (GO:0042698) | 2.83629302 |
| 128 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.81657823 |
| 129 | linoleic acid metabolic process (GO:0043651) | 2.81521271 |
| 130 | negative regulation of lipase activity (GO:0060192) | 2.80469440 |
| 131 | fatty acid beta-oxidation (GO:0006635) | 2.78971738 |
| 132 | alpha-linolenic acid metabolic process (GO:0036109) | 2.76686352 |
| 133 | neuronal action potential propagation (GO:0019227) | 2.76041115 |
| 134 | short-term memory (GO:0007614) | 2.75754702 |
| 135 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.74851451 |
| 136 | regulation of lipid catabolic process (GO:0050994) | 2.74728701 |
| 137 | negative regulation of metanephros development (GO:0072217) | 2.74494822 |
| 138 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.73600363 |
| 139 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.73486754 |
| 140 | transmission of nerve impulse (GO:0019226) | 2.71926843 |
| 141 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.71865747 |
| 142 | negative regulation of glial cell differentiation (GO:0045686) | 2.71483967 |
| 143 | carnitine transmembrane transport (GO:1902603) | 2.71417598 |
| 144 | somite development (GO:0061053) | 2.71209247 |
| 145 | * serine transport (GO:0032329) | 2.70186628 |
| 146 | import into cell (GO:0098657) | 2.70110999 |
| 147 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.69954978 |
| 148 | purine nucleotide transport (GO:0015865) | 2.69919714 |
| 149 | valine metabolic process (GO:0006573) | 2.69634314 |
| 150 | negative regulation of lipid storage (GO:0010888) | 2.68009036 |
| 151 | regulation of membrane repolarization (GO:0060306) | 2.67713422 |
| 152 | activation of protein kinase A activity (GO:0034199) | 2.67154513 |
| 153 | long-chain fatty acid transport (GO:0015909) | 2.66826673 |
| 154 | regulation of gonadotropin secretion (GO:0032276) | 2.65679363 |
| 155 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.65367240 |
| 156 | response to cholesterol (GO:0070723) | 2.64906386 |
| 157 | positive regulation of lipid catabolic process (GO:0050996) | 2.64688645 |
| 158 | myelination in peripheral nervous system (GO:0022011) | 2.64407845 |
| 159 | peripheral nervous system axon ensheathment (GO:0032292) | 2.64407845 |
| 160 | positive regulation of glycolytic process (GO:0045821) | 2.63463772 |
| 161 | synaptic transmission, glutamatergic (GO:0035249) | 2.62099982 |
| 162 | purine ribonucleotide transport (GO:0015868) | 2.57359141 |
| 163 | response to gravity (GO:0009629) | 2.54297721 |
| 164 | negative regulation of adenylate cyclase activity (GO:0007194) | 2.54271551 |
| 165 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.53280609 |
| 166 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.51383584 |
| 167 | endothelium development (GO:0003158) | 2.49625131 |
| 168 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.47903669 |
| 169 | neuron cell-cell adhesion (GO:0007158) | 2.47781791 |
| 170 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.46815298 |
| 171 | lens fiber cell development (GO:0070307) | 2.46807743 |
| 172 | triglyceride biosynthetic process (GO:0019432) | 2.45788920 |
| 173 | layer formation in cerebral cortex (GO:0021819) | 2.45157584 |
| 174 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 2.43000235 |
| 175 | vascular smooth muscle contraction (GO:0014829) | 2.42973985 |
| 176 | doxorubicin metabolic process (GO:0044598) | 2.41830476 |
| 177 | daunorubicin metabolic process (GO:0044597) | 2.41830476 |
| 178 | polyketide metabolic process (GO:0030638) | 2.41830476 |
| 179 | negative regulation of tissue remodeling (GO:0034104) | 2.41298352 |
| 180 | acyl-CoA biosynthetic process (GO:0071616) | 2.40539087 |
| 181 | thioester biosynthetic process (GO:0035384) | 2.40539087 |
| 182 | positive regulation of alcohol biosynthetic process (GO:1902932) | 2.40259999 |
| 183 | neutral lipid biosynthetic process (GO:0046460) | 2.39703979 |
| 184 | acylglycerol biosynthetic process (GO:0046463) | 2.39703979 |
| 185 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.39386465 |
| 186 | low-density lipoprotein particle clearance (GO:0034383) | 10.5831770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.76024286 |
| 2 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.64344987 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.19341842 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06011087 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.98453480 |
| 6 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.77202023 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67666293 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65255302 |
| 9 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65255302 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.64056393 |
| 11 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.62968012 |
| 12 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.48696136 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.48351647 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48042857 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.38883367 |
| 16 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36065438 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.31382958 |
| 18 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.28251966 |
| 19 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.26016254 |
| 20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.22622422 |
| 21 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20447827 |
| 22 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.17278310 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.11844830 |
| 24 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09770046 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.08963768 |
| 26 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.03964975 |
| 27 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.02430075 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.98668118 |
| 29 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.89706394 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.87710209 |
| 31 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87498722 |
| 32 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.83092495 |
| 33 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.82101231 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.81048453 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.73620963 |
| 36 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.73471590 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.71132460 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.70898071 |
| 39 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.68612652 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.62199081 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.61755585 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60820230 |
| 43 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.58715550 |
| 44 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.57632609 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.57477431 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55141197 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.50101051 |
| 48 | RXR_22108803_ChIP-Seq_LS180_Human | 1.48887485 |
| 49 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46245675 |
| 50 | P300_19829295_ChIP-Seq_ESCs_Human | 1.45105910 |
| 51 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.40775313 |
| 52 | TP53_16413492_ChIP-PET_HCT116_Human | 1.39835391 |
| 53 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33575494 |
| 54 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.32819708 |
| 55 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.32570718 |
| 56 | AR_25329375_ChIP-Seq_VCAP_Human | 1.31720834 |
| 57 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.28779396 |
| 58 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28457875 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.28177742 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27679898 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27547647 |
| 62 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.27183766 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.26482314 |
| 64 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.25814202 |
| 65 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.24617774 |
| 66 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.23945227 |
| 67 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20099413 |
| 68 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.19354578 |
| 69 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18718436 |
| 70 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.18670392 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18512035 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.18463867 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.17533658 |
| 74 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17389835 |
| 75 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.17032821 |
| 76 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.16553214 |
| 77 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.15956080 |
| 78 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15598812 |
| 79 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14209174 |
| 80 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.11781776 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09968243 |
| 82 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07111660 |
| 83 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06663656 |
| 84 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.06497726 |
| 85 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05656267 |
| 86 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.04892032 |
| 87 | AR_19668381_ChIP-Seq_PC3_Human | 1.03814740 |
| 88 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.02945140 |
| 89 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.02410140 |
| 90 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01982190 |
| 91 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01958589 |
| 92 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.00695429 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.00290477 |
| 94 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00271747 |
| 95 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99188414 |
| 96 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99110781 |
| 97 | STAT3_23295773_ChIP-Seq_U87_Human | 0.98232732 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97640185 |
| 99 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.96993305 |
| 100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95212108 |
| 101 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94679975 |
| 102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94265505 |
| 103 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.94124097 |
| 104 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94067573 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92706392 |
| 106 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91711912 |
| 107 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91695065 |
| 108 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91212546 |
| 109 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.90071143 |
| 110 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89921652 |
| 111 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89921652 |
| 112 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.89701833 |
| 113 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89501989 |
| 114 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88732102 |
| 115 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88594218 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.88249378 |
| 117 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87385011 |
| 118 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86655430 |
| 119 | TCF4_23295773_ChIP-Seq_U87_Human | 0.85544009 |
| 120 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.85507213 |
| 121 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84910989 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.84728136 |
| 123 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84605224 |
| 124 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.84340630 |
| 125 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.84238754 |
| 126 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.84182960 |
| 127 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84074083 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84074083 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.83852317 |
| 130 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83720239 |
| 131 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81803115 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.80995475 |
| 133 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.80700167 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.80513235 |
| 135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.79978557 |
| 136 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.78787916 |
| 137 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.77643399 |
| 138 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77608635 |
| 139 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77608635 |
| 140 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.77297452 |
| 141 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.77037635 |
| 142 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75234694 |
| 143 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.74984933 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.72642015 |
| 145 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.72519701 |
| 146 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.70543720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.02588023 |
| 2 | MP0003690_abnormal_glial_cell | 3.90135072 |
| 3 | MP0005670_abnormal_white_adipose | 3.42400335 |
| 4 | MP0002254_reproductive_system_inflammat | 3.28041895 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.15204270 |
| 6 | MP0005423_abnormal_somatic_nervous | 2.75481492 |
| 7 | MP0005171_absent_coat_pigmentation | 2.70225224 |
| 8 | MP0002970_abnormal_white_adipose | 2.66263252 |
| 9 | MP0004885_abnormal_endolymph | 2.63503670 |
| 10 | MP0001486_abnormal_startle_reflex | 2.54029262 |
| 11 | MP0003329_amyloid_beta_deposits | 2.51387164 |
| 12 | MP0004859_abnormal_synaptic_plasticity | 2.43434103 |
| 13 | MP0005448_abnormal_energy_balance | 2.32749608 |
| 14 | MP0003959_abnormal_lean_body | 2.26584366 |
| 15 | MP0000566_synostosis | 2.20567506 |
| 16 | MP0002638_abnormal_pupillary_reflex | 2.12727267 |
| 17 | * MP0003635_abnormal_synaptic_transmissio | 2.12319424 |
| 18 | MP0004270_analgesia | 2.10480793 |
| 19 | MP0003878_abnormal_ear_physiology | 2.04733770 |
| 20 | MP0005377_hearing/vestibular/ear_phenot | 2.04733770 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.02259318 |
| 22 | MP0005646_abnormal_pituitary_gland | 1.97540622 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.94694107 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.93652471 |
| 25 | MP0001501_abnormal_sleep_pattern | 1.93213670 |
| 26 | MP0004858_abnormal_nervous_system | 1.92854877 |
| 27 | MP0003880_abnormal_central_pattern | 1.86042216 |
| 28 | MP0009745_abnormal_behavioral_response | 1.83880698 |
| 29 | MP0004130_abnormal_muscle_cell | 1.82598400 |
| 30 | MP0005452_abnormal_adipose_tissue | 1.79905743 |
| 31 | MP0009384_cardiac_valve_regurgitation | 1.73572684 |
| 32 | MP0006138_congestive_heart_failure | 1.73434395 |
| 33 | MP0000003_abnormal_adipose_tissue | 1.71421619 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.68344388 |
| 35 | * MP0002064_seizures | 1.59724933 |
| 36 | MP0008569_lethality_at_weaning | 1.57977562 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.57776053 |
| 38 | MP0001502_abnormal_circadian_rhythm | 1.56134656 |
| 39 | MP0003075_altered_response_to | 1.53834562 |
| 40 | MP0003634_abnormal_glial_cell | 1.50946363 |
| 41 | MP0003279_aneurysm | 1.46390208 |
| 42 | * MP0009046_muscle_twitch | 1.45973100 |
| 43 | MP0003868_abnormal_feces_composition | 1.43484135 |
| 44 | MP0002733_abnormal_thermal_nociception | 1.43098611 |
| 45 | MP0005379_endocrine/exocrine_gland_phen | 1.41986493 |
| 46 | MP0002078_abnormal_glucose_homeostasis | 1.40539634 |
| 47 | MP0001485_abnormal_pinna_reflex | 1.39959207 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.39836839 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.39410169 |
| 50 | MP0004215_abnormal_myocardial_fiber | 1.38545164 |
| 51 | MP0002272_abnormal_nervous_system | 1.37589388 |
| 52 | MP0000604_amyloidosis | 1.36956325 |
| 53 | MP0002734_abnormal_mechanical_nocicepti | 1.35585577 |
| 54 | MP0006276_abnormal_autonomic_nervous | 1.34424772 |
| 55 | MP0002736_abnormal_nociception_after | 1.32180608 |
| 56 | MP0002067_abnormal_sensory_capabilities | 1.31243226 |
| 57 | MP0003186_abnormal_redox_activity | 1.29801798 |
| 58 | * MP0003633_abnormal_nervous_system | 1.27083480 |
| 59 | MP0002557_abnormal_social/conspecific_i | 1.24589428 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.22494237 |
| 61 | MP0002876_abnormal_thyroid_physiology | 1.22301121 |
| 62 | MP0005503_abnormal_tendon_morphology | 1.22041218 |
| 63 | MP0000343_altered_response_to | 1.21144596 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.18672539 |
| 65 | MP0003183_abnormal_peptide_metabolism | 1.18514790 |
| 66 | MP0010329_abnormal_lipoprotein_level | 1.18405781 |
| 67 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.17123101 |
| 68 | MP0002971_abnormal_brown_adipose | 1.16465017 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.15353310 |
| 70 | MP0002909_abnormal_adrenal_gland | 1.14601969 |
| 71 | MP0005386_behavior/neurological_phenoty | 1.13741292 |
| 72 | MP0004924_abnormal_behavior | 1.13741292 |
| 73 | MP0005595_abnormal_vascular_smooth | 1.13623869 |
| 74 | MP0003011_delayed_dark_adaptation | 1.13424511 |
| 75 | MP0001970_abnormal_pain_threshold | 1.12237714 |
| 76 | MP0001984_abnormal_olfaction | 1.11114312 |
| 77 | MP0004142_abnormal_muscle_tone | 1.10627290 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.10216644 |
| 79 | MP0009115_abnormal_fat_cell | 1.09809244 |
| 80 | MP0000013_abnormal_adipose_tissue | 1.09012556 |
| 81 | MP0002249_abnormal_larynx_morphology | 1.07645120 |
| 82 | * MP0003631_nervous_system_phenotype | 1.07021693 |
| 83 | MP0001963_abnormal_hearing_physiology | 1.06788884 |
| 84 | MP0003828_pulmonary_edema | 1.05527947 |
| 85 | MP0009379_abnormal_foot_pigmentation | 1.03806734 |
| 86 | MP0003948_abnormal_gas_homeostasis | 1.03462456 |
| 87 | MP0006036_abnormal_mitochondrial_physio | 1.03029420 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 1.02441229 |
| 89 | MP0005535_abnormal_body_temperature | 1.01542357 |
| 90 | MP0003646_muscle_fatigue | 1.00733037 |
| 91 | MP0002653_abnormal_ependyma_morphology | 1.00512157 |
| 92 | MP0003953_abnormal_hormone_level | 1.00360896 |
| 93 | MP0009840_abnormal_foam_cell | 1.00080477 |
| 94 | MP0003632_abnormal_nervous_system | 0.99908652 |
| 95 | MP0005647_abnormal_sex_gland | 0.99820911 |
| 96 | MP0003283_abnormal_digestive_organ | 0.99566347 |
| 97 | MP0004043_abnormal_pH_regulation | 0.98673267 |
| 98 | MP0001853_heart_inflammation | 0.97937425 |
| 99 | MP0004185_abnormal_adipocyte_glucose | 0.97809656 |
| 100 | MP0005167_abnormal_blood-brain_barrier | 0.97175193 |
| 101 | MP0005365_abnormal_bile_salt | 0.96339559 |
| 102 | MP0000026_abnormal_inner_ear | 0.95745249 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.94777094 |
| 104 | MP0001661_extended_life_span | 0.94399199 |
| 105 | MP0000751_myopathy | 0.94206537 |
| 106 | MP0000750_abnormal_muscle_regeneration | 0.94092456 |
| 107 | MP0001905_abnormal_dopamine_level | 0.92868665 |
| 108 | MP0000778_abnormal_nervous_system | 0.91639072 |
| 109 | MP0005253_abnormal_eye_physiology | 0.91394289 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.91231812 |
| 111 | MP0000049_abnormal_middle_ear | 0.90421823 |
| 112 | MP0006292_abnormal_olfactory_placode | 0.89313886 |
| 113 | MP0003724_increased_susceptibility_to | 0.88947108 |
| 114 | MP0001958_emphysema | 0.88896796 |
| 115 | MP0003879_abnormal_hair_cell | 0.88357245 |
| 116 | MP0002089_abnormal_postnatal_growth/wei | 0.87594666 |
| 117 | MP0000609_abnormal_liver_physiology | 0.86842419 |
| 118 | MP0005385_cardiovascular_system_phenoty | 0.85602899 |
| 119 | MP0001544_abnormal_cardiovascular_syste | 0.85602899 |
| 120 | MP0002069_abnormal_eating/drinking_beha | 0.85492096 |
| 121 | MP0009672_abnormal_birth_weight | 0.83740092 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.82226491 |
| 123 | MP0001944_abnormal_pancreas_morphology | 0.81947156 |
| 124 | MP0002837_dystrophic_cardiac_calcinosis | 0.80518836 |
| 125 | * MP0002066_abnormal_motor_capabilities/c | 0.80418310 |
| 126 | MP0001664_abnormal_digestion | 0.79746846 |
| 127 | MP0000920_abnormal_myelination | 0.77905836 |
| 128 | MP0002090_abnormal_vision | 0.77399130 |
| 129 | MP0004272_abnormal_basement_membrane | 0.76712314 |
| 130 | MP0001177_atelectasis | 0.76265570 |
| 131 | MP0002108_abnormal_muscle_morphology | 0.73721219 |
| 132 | MP0001299_abnormal_eye_distance/ | 0.73139980 |
| 133 | MP0005334_abnormal_fat_pad | 0.72022579 |
| 134 | MP0001881_abnormal_mammary_gland | 0.71706393 |
| 135 | MP0004742_abnormal_vestibular_system | 0.71683900 |
| 136 | MP0002229_neurodegeneration | 0.71467419 |
| 137 | MP0001764_abnormal_homeostasis | 0.67689427 |
| 138 | MP0001879_abnormal_lymphatic_vessel | 0.65140576 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.61319686 |
| 140 | MP0003122_maternal_imprinting | 0.59616068 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.59158997 |
| 142 | MP0002822_catalepsy | 0.57732654 |
| 143 | MP0001542_abnormal_bone_strength | 0.54438891 |
| 144 | * MP0005332_abnormal_amino_acid | 0.54397578 |
| 145 | MP0002133_abnormal_respiratory_system | 0.51686481 |
| 146 | MP0005388_respiratory_system_phenotype | 0.51686481 |
| 147 | MP0000249_abnormal_blood_vessel | 0.51535106 |
| 148 | MP0000759_abnormal_skeletal_muscle | 0.49601640 |
| 149 | MP0008438_abnormal_cutaneous_collagen | 0.48295334 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aplasia involving bones of the upper limbs (HP:0009823) | 7.01986856 |
| 2 | Aplasia of the phalanges of the hand (HP:0009802) | 7.01986856 |
| 3 | Aplasia involving bones of the extremities (HP:0009825) | 7.01986856 |
| 4 | Oligomenorrhea (HP:0000876) | 6.43992923 |
| 5 | Megalencephaly (HP:0001355) | 5.61653944 |
| 6 | Neurofibrillary tangles (HP:0002185) | 4.77351429 |
| 7 | Hemiparesis (HP:0001269) | 4.66143411 |
| 8 | Abnormality of the axillary hair (HP:0100134) | 4.57264787 |
| 9 | Abnormality of secondary sexual hair (HP:0009888) | 4.57264787 |
| 10 | Long foot (HP:0001833) | 4.46880783 |
| 11 | Abnormality of binocular vision (HP:0011514) | 4.35831787 |
| 12 | Diplopia (HP:0000651) | 4.35831787 |
| 13 | Hemiplegia (HP:0002301) | 4.20592566 |
| 14 | Epidermoid cyst (HP:0200040) | 4.17442636 |
| 15 | Hypoplastic left heart (HP:0004383) | 4.16526161 |
| 16 | Bone cyst (HP:0012062) | 4.04215190 |
| 17 | Prominent supraorbital ridges (HP:0000336) | 4.00530185 |
| 18 | Growth hormone excess (HP:0000845) | 3.90599254 |
| 19 | Xanthomatosis (HP:0000991) | 3.78192273 |
| 20 | Insulin resistance (HP:0000855) | 3.71888707 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 3.66632869 |
| 22 | Humeroradial synostosis (HP:0003041) | 3.55212517 |
| 23 | Synostosis involving the elbow (HP:0003938) | 3.55212517 |
| 24 | Nausea (HP:0002018) | 3.52890223 |
| 25 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.38189048 |
| 26 | Increased serum pyruvate (HP:0003542) | 3.34978543 |
| 27 | Pigmentary retinal degeneration (HP:0001146) | 3.31314222 |
| 28 | Mixed hearing impairment (HP:0000410) | 3.28636043 |
| 29 | Focal motor seizures (HP:0011153) | 3.21307377 |
| 30 | Increased muscle lipid content (HP:0009058) | 3.20658956 |
| 31 | Abnormality of alanine metabolism (HP:0010916) | 3.19727589 |
| 32 | Hyperalaninemia (HP:0003348) | 3.19727589 |
| 33 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.19727589 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.15510349 |
| 35 | Tetraparesis (HP:0002273) | 3.14291319 |
| 36 | Hypoplastic heart (HP:0001961) | 3.11960675 |
| 37 | Clumsiness (HP:0002312) | 3.10284828 |
| 38 | Onycholysis (HP:0001806) | 3.09042017 |
| 39 | Axonal loss (HP:0003447) | 3.04358372 |
| 40 | Difficulty running (HP:0009046) | 2.99756920 |
| 41 | Skin nodule (HP:0200036) | 2.95642343 |
| 42 | Hyperglycinuria (HP:0003108) | 2.91036423 |
| 43 | Myocardial infarction (HP:0001658) | 2.86157387 |
| 44 | Mesangial abnormality (HP:0001966) | 2.85986583 |
| 45 | Back pain (HP:0003418) | 2.76675047 |
| 46 | Hypoalphalipoproteinemia (HP:0003233) | 2.76324288 |
| 47 | Epileptic encephalopathy (HP:0200134) | 2.76267545 |
| 48 | Split foot (HP:0001839) | 2.76200425 |
| 49 | Narrow nasal bridge (HP:0000446) | 2.75804920 |
| 50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.73068106 |
| 51 | Absent hair (HP:0002298) | 2.71999617 |
| 52 | Large for gestational age (HP:0001520) | 2.68757207 |
| 53 | Abnormality of glycolysis (HP:0004366) | 2.66314121 |
| 54 | Myoglobinuria (HP:0002913) | 2.64273628 |
| 55 | Long nose (HP:0003189) | 2.63400792 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.61348755 |
| 57 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.60434644 |
| 58 | Short middle phalanx of the 5th finger (HP:0004220) | 2.59088607 |
| 59 | Rhabdomyolysis (HP:0003201) | 2.56705395 |
| 60 | Protrusio acetabuli (HP:0003179) | 2.56270365 |
| 61 | Abnormality of the dental pulp (HP:0006479) | 2.55479881 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.53502784 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.53502784 |
| 64 | Confusion (HP:0001289) | 2.51076798 |
| 65 | Abnormal eating behavior (HP:0100738) | 2.49609728 |
| 66 | Accelerated skeletal maturation (HP:0005616) | 2.46922522 |
| 67 | Supranuclear gaze palsy (HP:0000605) | 2.44532482 |
| 68 | Complement deficiency (HP:0004431) | 2.42795297 |
| 69 | Maternal diabetes (HP:0009800) | 2.41196103 |
| 70 | Infantile muscular hypotonia (HP:0008947) | 2.40280290 |
| 71 | Broad metatarsal (HP:0001783) | 2.39867554 |
| 72 | Short hallux (HP:0010109) | 2.39840144 |
| 73 | Bronchomalacia (HP:0002780) | 2.39254009 |
| 74 | Abnormal hemoglobin (HP:0011902) | 2.38671873 |
| 75 | Broad alveolar ridges (HP:0000187) | 2.38155923 |
| 76 | Status epilepticus (HP:0002133) | 2.34848723 |
| 77 | Paraparesis (HP:0002385) | 2.34523656 |
| 78 | Fibular aplasia (HP:0002990) | 2.34155589 |
| 79 | Impulsivity (HP:0100710) | 2.30413026 |
| 80 | Pseudobulbar signs (HP:0002200) | 2.29077652 |
| 81 | White forelock (HP:0002211) | 2.28646607 |
| 82 | Amyloidosis (HP:0011034) | 2.26755334 |
| 83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.26454636 |
| 84 | Ectopia lentis (HP:0001083) | 2.26195927 |
| 85 | Hyperlipoproteinemia (HP:0010980) | 2.25933507 |
| 86 | Oligodactyly (hands) (HP:0001180) | 2.22228168 |
| 87 | Hypoglycemic coma (HP:0001325) | 2.21945913 |
| 88 | Acanthosis nigricans (HP:0000956) | 2.21108494 |
| 89 | Pulmonary artery stenosis (HP:0004415) | 2.20140299 |
| 90 | Large hands (HP:0001176) | 2.20054552 |
| 91 | Osteomalacia (HP:0002749) | 2.19120019 |
| 92 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.18801372 |
| 93 | Adactyly (HP:0009776) | 2.17112833 |
| 94 | Hypercortisolism (HP:0001578) | 2.16593821 |
| 95 | Focal seizures (HP:0007359) | 2.15729290 |
| 96 | Nasolacrimal duct obstruction (HP:0000579) | 2.14573764 |
| 97 | Abnormality of molar morphology (HP:0011070) | 2.12702366 |
| 98 | Abnormality of molar (HP:0011077) | 2.12702366 |
| 99 | Neonatal onset (HP:0003623) | 2.12654950 |
| 100 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.11789248 |
| 101 | Generalized tonic-clonic seizures (HP:0002069) | 2.11777018 |
| 102 | Partial duplication of thumb phalanx (HP:0009944) | 2.11520019 |
| 103 | Abnormality of nail color (HP:0100643) | 2.06588227 |
| 104 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.06247423 |
| 105 | Absent/shortened dynein arms (HP:0200106) | 2.06247423 |
| 106 | Neonatal short-limb short stature (HP:0008921) | 2.05710256 |
| 107 | Hypertriglyceridemia (HP:0002155) | 2.05128248 |
| 108 | Ileus (HP:0002595) | 2.05037333 |
| 109 | Abnormality of the dental root (HP:0006486) | 2.05033407 |
| 110 | Taurodontia (HP:0000679) | 2.05033407 |
| 111 | Abnormality of permanent molar morphology (HP:0011071) | 2.05033407 |
| 112 | Polyphagia (HP:0002591) | 2.04692948 |
| 113 | Patchy hypopigmentation of hair (HP:0011365) | 2.04219560 |
| 114 | Action tremor (HP:0002345) | 2.04014609 |
| 115 | Opisthotonus (HP:0002179) | 2.03872787 |
| 116 | Turricephaly (HP:0000262) | 2.03835344 |
| 117 | Subcapsular cataract (HP:0000523) | 1.98569330 |
| 118 | Potter facies (HP:0002009) | 1.96470060 |
| 119 | Facial shape deformation (HP:0011334) | 1.96470060 |
| 120 | Craniofacial hyperostosis (HP:0004493) | 1.96108512 |
| 121 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.94198410 |
| 122 | Easy fatigability (HP:0003388) | 1.93888708 |
| 123 | Mutism (HP:0002300) | 1.93559392 |
| 124 | Dicarboxylic aciduria (HP:0003215) | 1.93096037 |
| 125 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.93096037 |
| 126 | Multifactorial inheritance (HP:0001426) | 1.91783232 |
| 127 | Abnormality of the lacrimal duct (HP:0011481) | 1.90944406 |
| 128 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.90542000 |
| 129 | Retinal atrophy (HP:0001105) | 1.89583855 |
| 130 | Renal tubular acidosis (HP:0001947) | 1.88922239 |
| 131 | Dysdiadochokinesis (HP:0002075) | 1.88586066 |
| 132 | Myokymia (HP:0002411) | 1.87564030 |
| 133 | Progressive cerebellar ataxia (HP:0002073) | 1.87041626 |
| 134 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.86234453 |
| 135 | Vascular tortuosity (HP:0004948) | 1.85527356 |
| 136 | Rickets (HP:0002748) | 1.85357333 |
| 137 | Inability to walk (HP:0002540) | 1.84740603 |
| 138 | Gowers sign (HP:0003391) | 1.83795735 |
| 139 | Partial duplication of the phalanx of hand (HP:0009999) | 1.83727508 |
| 140 | Coronal craniosynostosis (HP:0004440) | 1.83026808 |
| 141 | Spastic paraparesis (HP:0002313) | 1.83005888 |
| 142 | Slow-growing hair (HP:0002217) | 1.82681044 |
| 143 | Abnormality of hair growth rate (HP:0011363) | 1.82681044 |
| 144 | Polar cataract (HP:0010696) | 1.82460610 |
| 145 | Polygenic inheritance (HP:0010982) | 1.80996671 |
| 146 | Sprengel anomaly (HP:0000912) | 1.79386397 |
| 147 | Abnormality of the periventricular white matter (HP:0002518) | 1.79325453 |
| 148 | Arterial tortuosity (HP:0005116) | 1.78858632 |
| 149 | Abnormality of the labia (HP:0000058) | 1.77126502 |
| 150 | Hypoplastic pelvis (HP:0008839) | 1.76708153 |
| 151 | Alacrima (HP:0000522) | 1.74464334 |
| 152 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.74196435 |
| 153 | Limb dystonia (HP:0002451) | 1.74139660 |
| 154 | Vertebral compression fractures (HP:0002953) | 1.73839254 |
| 155 | Abnormal social behavior (HP:0012433) | 1.73529940 |
| 156 | Impaired social interactions (HP:0000735) | 1.73529940 |
| 157 | Postural instability (HP:0002172) | 1.73172663 |
| 158 | Prenatal maternal abnormality (HP:0002686) | 1.72228757 |
| 159 | Abnormality of the nasolacrimal system (HP:0000614) | 1.71983029 |
| 160 | Cranial hyperostosis (HP:0004437) | 1.70474026 |
| 161 | Absent toe (HP:0010760) | 1.69420027 |
| 162 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.69068611 |
| 163 | Megalocornea (HP:0000485) | 1.68885359 |
| 164 | Thyroid-stimulating hormone excess (HP:0002925) | 1.68289411 |
| 165 | Soft skin (HP:0000977) | 1.67134180 |
| 166 | Thickened helices (HP:0000391) | 1.67067433 |
| 167 | Polycythemia (HP:0001901) | 1.66999740 |
| 168 | Dry hair (HP:0011359) | 1.66644301 |
| 169 | Abnormality of the diencephalon (HP:0010662) | 1.66381686 |
| 170 | Spastic tetraparesis (HP:0001285) | 1.66358527 |
| 171 | Atonic seizures (HP:0010819) | 1.66218417 |
| 172 | Hydroxyprolinuria (HP:0003080) | 1.65892221 |
| 173 | Abnormality of proline metabolism (HP:0010907) | 1.65892221 |
| 174 | Tetraplegia (HP:0002445) | 1.65501034 |
| 175 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 1.65153407 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.76155954 |
| 2 | TNIK | 4.55066619 |
| 3 | LMTK2 | 4.40824180 |
| 4 | PHKG1 | 3.73976019 |
| 5 | PHKG2 | 3.73976019 |
| 6 | PRKD3 | 3.35739862 |
| 7 | MAPK15 | 3.29076874 |
| 8 | NTRK2 | 2.60956160 |
| 9 | SIK1 | 2.46956899 |
| 10 | PNCK | 2.41775104 |
| 11 | CASK | 2.27161042 |
| 12 | CAMK1D | 2.20618984 |
| 13 | NTRK3 | 1.99655264 |
| 14 | CAMK1G | 1.98567204 |
| 15 | LATS2 | 1.87751067 |
| 16 | TRIB3 | 1.83406440 |
| 17 | MAPK13 | 1.80387893 |
| 18 | MUSK | 1.80363620 |
| 19 | MAP3K13 | 1.79783075 |
| 20 | BMPR1B | 1.72061067 |
| 21 | CAMKK1 | 1.69472867 |
| 22 | TIE1 | 1.63949635 |
| 23 | MAPK4 | 1.63758435 |
| 24 | MAPK12 | 1.56883645 |
| 25 | INSRR | 1.51516902 |
| 26 | IRAK3 | 1.50573183 |
| 27 | ABL2 | 1.48378425 |
| 28 | MINK1 | 1.42789157 |
| 29 | TNK2 | 1.41867730 |
| 30 | TGFBR2 | 1.40176608 |
| 31 | MKNK2 | 1.36782314 |
| 32 | MAP2K7 | 1.35054819 |
| 33 | SGK2 | 1.31920236 |
| 34 | WNK4 | 1.30588987 |
| 35 | MAP3K11 | 1.26611126 |
| 36 | MARK1 | 1.19650568 |
| 37 | PIK3CA | 1.19324136 |
| 38 | SGK494 | 1.18799075 |
| 39 | SGK223 | 1.18799075 |
| 40 | PRKAA2 | 1.16450292 |
| 41 | MAP3K4 | 1.11788928 |
| 42 | FGFR2 | 1.08344479 |
| 43 | MAP2K1 | 1.06336143 |
| 44 | SGK3 | 1.05811798 |
| 45 | GRK1 | 1.04378885 |
| 46 | DYRK2 | 1.02857933 |
| 47 | GSK3A | 1.02096293 |
| 48 | EPHA3 | 0.98545864 |
| 49 | TSSK6 | 0.97945806 |
| 50 | PRKD2 | 0.97541727 |
| 51 | NEK6 | 0.96925603 |
| 52 | CDK3 | 0.96892371 |
| 53 | TESK1 | 0.96525908 |
| 54 | BLK | 0.96210079 |
| 55 | PRKCG | 0.94921800 |
| 56 | PRKCE | 0.89984620 |
| 57 | FGR | 0.87227024 |
| 58 | DDR2 | 0.85964692 |
| 59 | CDK6 | 0.84603820 |
| 60 | CDK5 | 0.84065116 |
| 61 | PRKCH | 0.83712900 |
| 62 | DYRK1A | 0.80870835 |
| 63 | RIPK1 | 0.80311769 |
| 64 | PINK1 | 0.80039314 |
| 65 | FES | 0.79752613 |
| 66 | PAK6 | 0.79091633 |
| 67 | MYLK | 0.77041967 |
| 68 | FGFR3 | 0.76137152 |
| 69 | CAMK4 | 0.74197051 |
| 70 | ADRBK1 | 0.74194034 |
| 71 | AKT3 | 0.72507230 |
| 72 | NLK | 0.71815108 |
| 73 | MAPK7 | 0.70471463 |
| 74 | MAP3K7 | 0.69994916 |
| 75 | MAP2K4 | 0.67038419 |
| 76 | PDK4 | 0.66575047 |
| 77 | PDK3 | 0.66575047 |
| 78 | STK11 | 0.65988247 |
| 79 | CDC42BPA | 0.65285202 |
| 80 | CAMK2A | 0.64242236 |
| 81 | CDK9 | 0.63696519 |
| 82 | NTRK1 | 0.63053109 |
| 83 | WNK3 | 0.62749590 |
| 84 | CAMK1 | 0.61725678 |
| 85 | MAPKAPK5 | 0.61236611 |
| 86 | PKN2 | 0.60971618 |
| 87 | PDGFRB | 0.60589732 |
| 88 | ARAF | 0.60570785 |
| 89 | SGK1 | 0.60305269 |
| 90 | ROCK1 | 0.60048630 |
| 91 | PDPK1 | 0.58838285 |
| 92 | IGF1R | 0.58133083 |
| 93 | STK38 | 0.57889295 |
| 94 | ILK | 0.57048882 |
| 95 | PKN1 | 0.55241666 |
| 96 | DAPK3 | 0.55240431 |
| 97 | DYRK3 | 0.52549306 |
| 98 | TYRO3 | 0.51124979 |
| 99 | PRKACG | 0.48845188 |
| 100 | FLT3 | 0.48322815 |
| 101 | PAK3 | 0.48022838 |
| 102 | PDGFRA | 0.47814993 |
| 103 | FGFR1 | 0.46885574 |
| 104 | MAP2K2 | 0.46747272 |
| 105 | GRK5 | 0.46102555 |
| 106 | PRKACA | 0.46056739 |
| 107 | RIPK4 | 0.46003366 |
| 108 | PRKCA | 0.45893023 |
| 109 | JAK2 | 0.45862865 |
| 110 | DAPK2 | 0.44692732 |
| 111 | MAPK3 | 0.44017496 |
| 112 | DMPK | 0.43808849 |
| 113 | PRKACB | 0.43577209 |
| 114 | PRKAA1 | 0.43408172 |
| 115 | ROCK2 | 0.43270559 |
| 116 | SRC | 0.43187151 |
| 117 | BMX | 0.42951512 |
| 118 | PRKD1 | 0.42198177 |
| 119 | PRKCQ | 0.41966535 |
| 120 | ERN1 | 0.41835806 |
| 121 | MAP3K9 | 0.41590965 |
| 122 | ADRBK2 | 0.41551611 |
| 123 | RPS6KA3 | 0.41346103 |
| 124 | ICK | 0.41002199 |
| 125 | PAK2 | 0.40871384 |
| 126 | MAP3K6 | 0.40664126 |
| 127 | WNK1 | 0.40643045 |
| 128 | CAMK2G | 0.40175879 |
| 129 | BCKDK | 0.39726231 |
| 130 | PRPF4B | 0.39227295 |
| 131 | PRKG1 | 0.38536558 |
| 132 | RPS6KA6 | 0.38226209 |
| 133 | PDK1 | 0.38048575 |
| 134 | AKT2 | 0.37162547 |
| 135 | CDK4 | 0.36172598 |
| 136 | CDK8 | 0.35479204 |
| 137 | EPHB2 | 0.35350798 |
| 138 | IRAK1 | 0.34960686 |
| 139 | AKT1 | 0.34730219 |
| 140 | RPS6KA2 | 0.33878228 |
| 141 | SIK2 | 0.33172741 |
| 142 | ERBB4 | 0.33125936 |
| 143 | PRKCZ | 0.32958383 |
| 144 | FER | 0.32762732 |
| 145 | FYN | 0.32442621 |
| 146 | CAMKK2 | 0.30539298 |
| 147 | MARK2 | 0.30257584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 5.81284411 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.17453329 |
| 3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.59928298 |
| 4 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.84411360 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.71857806 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.65228594 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.35372416 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 2.24938583 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.24038026 |
| 10 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.12794402 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.88765868 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 1.86523246 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.82800335 |
| 14 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.77623296 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.70381473 |
| 16 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.69963998 |
| 17 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.66543492 |
| 18 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.62618266 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.50231741 |
| 20 | Morphine addiction_Homo sapiens_hsa05032 | 1.49064092 |
| 21 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.48916574 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.38046871 |
| 23 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.33551971 |
| 24 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33083951 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32671446 |
| 26 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31815412 |
| 27 | Insulin secretion_Homo sapiens_hsa04911 | 1.30194277 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.29147984 |
| 29 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.25086046 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.24972164 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.23138398 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21582880 |
| 33 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.19846940 |
| 34 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19065487 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.18112070 |
| 36 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.15706825 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15157878 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.12309067 |
| 39 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03795170 |
| 40 | Cocaine addiction_Homo sapiens_hsa05030 | 1.00266704 |
| 41 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.98476905 |
| 42 | Long-term potentiation_Homo sapiens_hsa04720 | 0.97894481 |
| 43 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.97755957 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97528339 |
| 45 | Taste transduction_Homo sapiens_hsa04742 | 0.97494970 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.97160901 |
| 47 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96220308 |
| 48 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95515484 |
| 49 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.94268621 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91783509 |
| 51 | Peroxisome_Homo sapiens_hsa04146 | 0.90744496 |
| 52 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.90505532 |
| 53 | Mineral absorption_Homo sapiens_hsa04978 | 0.88316318 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.85082468 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.84025333 |
| 56 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.83299290 |
| 57 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81846704 |
| 58 | Circadian rhythm_Homo sapiens_hsa04710 | 0.81088245 |
| 59 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.80426433 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.80372831 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77886427 |
| 62 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.77332508 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.75658377 |
| 64 | Long-term depression_Homo sapiens_hsa04730 | 0.74503122 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73777333 |
| 66 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71309802 |
| 67 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.69626341 |
| 68 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.69070250 |
| 69 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.68917776 |
| 70 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.67528021 |
| 71 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.67513013 |
| 72 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.65101901 |
| 73 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.64132996 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.63262287 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62987173 |
| 76 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62860324 |
| 77 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59452460 |
| 78 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.58749855 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57892740 |
| 80 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.57753774 |
| 81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57252135 |
| 82 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56460944 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.55747737 |
| 84 | Gap junction_Homo sapiens_hsa04540 | 0.55560045 |
| 85 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.52729389 |
| 86 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.52636238 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.52567572 |
| 88 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51449556 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48567351 |
| 90 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.47280815 |
| 91 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47205958 |
| 92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.46884341 |
| 93 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.46865507 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46794529 |
| 95 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46743680 |
| 96 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46724909 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.46163173 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45688196 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45444292 |
| 100 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.44989711 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.44428368 |
| 102 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42958538 |
| 103 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.42413535 |
| 104 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42292653 |
| 105 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.41318474 |
| 106 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.41258110 |
| 107 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40746750 |
| 108 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.40675715 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40164663 |
| 110 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.39777623 |
| 111 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39776406 |
| 112 | ABC transporters_Homo sapiens_hsa02010 | 0.39148167 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.39064647 |
| 114 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.38910796 |
| 115 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.37553794 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37467128 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37262609 |
| 118 | Axon guidance_Homo sapiens_hsa04360 | 0.36871166 |
| 119 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.36589761 |
| 120 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.36350189 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.34911639 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.34435824 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33093619 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32228447 |
| 125 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30577177 |
| 126 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.30027356 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28529676 |
| 128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27418206 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.27339267 |
| 130 | Parkinsons disease_Homo sapiens_hsa05012 | 0.22247381 |
| 131 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20356756 |
| 132 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.20351794 |
| 133 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.19919800 |

